ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin,
- This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors.
http://abstracts.asco.org/144/AbstView_144_133450.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.